- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06699251
Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
March 4, 2026 updated by: RAND
Effectiveness of Brief Intervention in Primary Care for Diverse Young People
Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The six-item CRAFFT will be used to screen teens at our partner clinics for risky AC use.
For those that screen in as at-risk and express interest in the study, the teen's case manager will complete an online consent/assent form with the parent and teen that contains contact information for the teen so that investigators can follow up with the teen for surveys and intervention delivery or for providing an informational brochure.
When the online consent/assent form is completed, the teen will be sent a personalized link to complete their baseline survey.
Upon survey completion, the teen will receive a link that has their electronic gift card payment, and the case manager will be notified that a particular ID has completed the survey.
The case manager will be informed by study staff whether to schedule that ID for enhanced usual care (EUC) or the Chat intervention.
Investigators expect each teen to be scheduled within 30 days of completing their baseline survey to receive EUC or Chat.
The informational brochure for the EUC will be handed to the teen during the visit or securely emailed, and Chat could take place either via a virtual or in-person visit.
Whether or not the teen completes EUC or Chat, every teen will be followed by the RAND Survey Research Group to complete their follow-up web-based surveys based on timing of completion of their baseline survey.
Teens will receive gift card incentives for completing the 3-month, 6-month, and 12-month surveys.
Investigators will begin recruitment in month 9 of the project.
Briefly, investigators expect to recruit from study month 9 to month 42 for the baseline survey.
Investigators expect the Chat intervention to occur from months 9 to 42 the 3-month follow-up from months 12 to 45, 6-month from months 15 to 48, and the 12-month from months 21 to 53.
Out of an anticipated 5,644 clients that our partner clinics will screen, investigators expect approximately 847 (15%) to screen in as at-risk on the CRAFFT and anticipate that approximately 500 (~60%) will consent into the study.
Study Type
Interventional
Enrollment (Estimated)
500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elizabeth J D'Amico, PhD
- Phone Number: 6487 3103930411
- Email: damico@rand.org
Study Contact Backup
- Name: Michael J Woodward
- Phone Number: 6595 3103930411
- Email: michaelw@rand.org
Study Locations
-
-
California
-
Commerce, California, United States, 90022
- Recruiting
- AltaMed Health Services
-
Contact:
- Sandra Pisano
- Phone Number: 888-499-9303
- Email: SPisano@altamed.org
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh Medical Center Children's Hospital
-
Contact:
- Ana Radovic
- Phone Number: 412-692-6677
- Email: Ana.Radovic@chp.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- receive health care at one of two participating health systems
- aged 12-17
- screen positive for being at risk for alcohol or cannabis use using the CRAFFT
Exclusion Criteria:
- if they don't meet the inclusion criteria, they will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Enhanced Usual Care
When the online consent/assent form is completed, the teen will be sent a personalized link to complete their baseline survey.
Upon survey completion, the teen will receive a link that has their electronic gift card payment, and the case manager will be notified that a particular ID has completed the survey.
The case manager will be informed by study staff whether to schedule that ID for enhanced usual care (EUC) or the Chat intervention.
If they are randomized as EUC, the informational brochure for the EUC will be handed to the teen during the visit or securely emailed to them.
Whether the teen completes EUC or Chat, every teen will be followed by the RAND Survey Research Group to complete their paid follow-up web-based surveys based on timing of completion of their baseline survey.
|
An informational brochure will be give to partner clinic participants with an alcohol or cannabis use condition.
|
|
Experimental: Chat Intervention
When the online consent/assent form is completed, the teen will be sent a personalized link to complete their baseline survey.
Upon survey completion, the teen will receive a link that has their electronic gift card payment, and the case manager will be notified that a particular ID has completed the survey.
The case manager will be informed by study staff whether to schedule that ID for enhanced usual care (EUC) or the Chat Intervention.
If they are randomized as Chat Intervention, Chat will take place either via a virtual or in-person visit.
Whether the teen completes EUC or Chat, every teen will be followed by the RAND Survey Research Group to complete their paid follow-up web-based surveys based on timing of completion of their baseline survey.
|
Chat is a brief motivational interviewing intervention for partner clinic participants with an alcohol or cannabis use condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol - change in frequency of use
Time Frame: Baseline to 3 months
|
We will assess both the number of times participants have used alcohol in the past three months (from none to 31 or more times) and the number of days in the past month participants report use of alcohol.
|
Baseline to 3 months
|
|
Alcohol - change in frequency of use
Time Frame: 3 months to 6 months
|
We will assess both the number of times participants have used alcohol in the past three months (from none to 31 or more times) and the number of days in the past month participants report use of alcohol.
|
3 months to 6 months
|
|
Alcohol - change in frequency of use
Time Frame: 6 months to 12 months
|
We will assess both the number of times participants have used alcohol in the past six months (from none to 31 or more times) and the number of days in the past month participants report use of alcohol.
|
6 months to 12 months
|
|
Cannabis - change in frequency of use
Time Frame: Baseline to 3 months
|
We will assess both the number of times participants have used cannabis in the past three months (from none to 31 or more times) and the number of days in the past month participants report use of cannabis.
|
Baseline to 3 months
|
|
Cannabis - change in frequency of use
Time Frame: 3 months to 6 months
|
We will assess both the number of times participants have used cannabis in the past three months (from none to 31 or more times) and the number of days in the past month participants report use of cannabis.
|
3 months to 6 months
|
|
Cannabis - change in frequency of use
Time Frame: 6 months to 12 months
|
We will assess both the number of times participants have used cannabis in the past six months (from none to 31 or more times) and the number of days in the past month participants report use of cannabis.
|
6 months to 12 months
|
|
Alcohol - change in consequences of use
Time Frame: Baseline to 3 months
|
Alcohol consequences (e.g., blacking out, regretted sexual situation) will be assessed with the Brief Young Adult Alcohol Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
Baseline to 3 months
|
|
Alcohol - change in consequences of use
Time Frame: 3 months to 6 months
|
Alcohol consequences (e.g., blacking out, regretted sexual situation) will be assessed with the Brief Young Adult Alcohol Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
3 months to 6 months
|
|
Alcohol - change in consequences of use
Time Frame: 6 months to 12 months
|
Alcohol consequences (e.g., blacking out, regretted sexual situation) will be assessed with the Brief Young Adult Alcohol Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
6 months to 12 months
|
|
Cannabis - change in consequences of use
Time Frame: Baseline to 3 months
|
Cannabis consequences (e.g., poor memory, too much time using) will be assessed with the Brief Marijuana Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
Baseline to 3 months
|
|
Cannabis - change in consequences of use
Time Frame: 3 months to 6 months
|
Cannabis consequences (e.g., poor memory, too much time using) will be assessed with the Brief Marijuana Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
3 months to 6 months
|
|
Cannabis - change in consequences of use
Time Frame: 6 months to 12 months
|
Cannabis consequences (e.g., poor memory, too much time using) will be assessed with the Brief Marijuana Consequences Questionnaire (0 to 20 or more times, with higher scores indicating a worse outcome).
|
6 months to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol - change in time spent around peers
Time Frame: Baseline to 3 months
|
Participants will be asked how often they are with people their age who are using alcohol (1=never to 4=often).
|
Baseline to 3 months
|
|
Alcohol - change in time spent around peers
Time Frame: 3 months to 6 months
|
Participants will be asked how often they are with people their age who are using alcohol (1=never to 4=often).
|
3 months to 6 months
|
|
Alcohol - change in time spent around peers
Time Frame: 6 months to 12 months
|
Participants will be asked how often they are with people their age who are using alcohol (1=never to 4=often).
|
6 months to 12 months
|
|
Cannabis - change in time spent around peers
Time Frame: Baseline to 3 months
|
Participants will be asked how often they are with people their age who are using cannabis (1=never to 4=often).
|
Baseline to 3 months
|
|
Cannabis - change in time spent around peers
Time Frame: 3 months to 6 months
|
Participants will be asked how often they are with people their age who are using cannabis (1=never to 4=often).
|
3 months to 6 months
|
|
Cannabis - change in time spent around peers
Time Frame: 6 months to 12 months
|
Participants will be asked how often they are with people their age who are using cannabis (1=never to 4=often).
|
6 months to 12 months
|
|
Alcohol - change in motivation to change use
Time Frame: Baseline to 3 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their alcohol use using a scale of 1-10 where 1 = "I have quit using alcohol and will never go back" and 10 = "I enjoy using alcohol and have decided never to change it."
|
Baseline to 3 months
|
|
Alcohol - change in motivation to change use
Time Frame: 3 months to 6 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their alcohol use using a scale of 1-10 where 1 = "I have quit using alcohol and will never go back" and 10 = "I enjoy using alcohol and have decided never to change it."
|
3 months to 6 months
|
|
Alcohol - change in motivation to change use
Time Frame: 6 months to 12 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their alcohol use using a scale of 1-10 where 1 = "I have quit using alcohol and will never go back" and 10 = "I enjoy using alcohol and have decided never to change it."
|
6 months to 12 months
|
|
Cannabis - change in motivation to change use
Time Frame: Baseline to 3 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their cannabis use using a scale of 1-10 where 1 = "I have quit using cannabis and will never go back" and 10 = "I enjoy using cannabis and have decided never to change it."
|
Baseline to 3 months
|
|
Cannabis - change in motivation to change use
Time Frame: 3 months to 6 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their cannabis use using a scale of 1-10 where 1 = "I have quit using cannabis and will never go back" and 10 = "I enjoy using cannabis and have decided never to change it."
|
3 months to 6 months
|
|
Cannabis - change in motivation to change use
Time Frame: 6 months to 12 months
|
We will measure motivation to change use by asking participants where they may be in their thinking about reducing or quitting their cannabis use using a scale of 1-10 where 1 = "I have quit using cannabis and will never go back" and 10 = "I enjoy using cannabis and have decided never to change it."
|
6 months to 12 months
|
|
Change in use of behavioral health care services
Time Frame: Baseline to 3 months
|
We will measure use of behavioral health care services (separate items for mental health and substance use), including whether there are unmet needs for behavioral health services (i.e., perceived a need to get treatment but didn't get it) and perceived reasons for those unmet needs (e.g., stigma, transportation, cost).
|
Baseline to 3 months
|
|
Change in use of behavioral health care services
Time Frame: 3 months to 6 months
|
We will measure use of behavioral health care services (separate items for mental health and substance use), including whether there are unmet needs for behavioral health services (i.e., perceived a need to get treatment but didn't get it) and perceived reasons for those unmet needs (e.g., stigma, transportation, cost).
|
3 months to 6 months
|
|
Change in use of behavioral health care services
Time Frame: 6 months to 12 months
|
We will measure use of behavioral health care services (separate items for mental health and substance use), including whether there are unmet needs for behavioral health services (i.e., perceived a need to get treatment but didn't get it) and perceived reasons for those unmet needs (e.g., stigma, transportation, cost).
|
6 months to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth J. D'Amico, PhD, RAND
- Principal Investigator: Alina I Palimaru, PhD, RAND
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 28, 2025
Primary Completion (Estimated)
July 28, 2028
Study Completion (Estimated)
February 28, 2029
Study Registration Dates
First Submitted
November 15, 2024
First Submitted That Met QC Criteria
November 18, 2024
First Posted (Actual)
November 21, 2024
Study Record Updates
Last Update Posted (Actual)
March 6, 2026
Last Update Submitted That Met QC Criteria
March 4, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-N0065
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use
-
University of MinnesotaNot yet recruitingCannabis Use | Cannabis Use DisorderUnited States
-
Anders Fink-Jensen, MD, DMSciNeurobiology Research Unit, RigshospitaletRecruitingCannabis Dependence | Cannabis Abuse | Cannabis Use Disorder | Cannabis Use Disorders | Cannabis AddictionDenmark
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingMarijuana Abuse | Marijuana Use | Addiction | Substance Use | Cannabis Dependence | Substance Use Disorders | Cannabis Use | Substance Abuse | Addiction, Substance | Marijuana Dependence | Substance Dependence | Marijuana Smoking | Cannabis Abuse | Cannabis Use Disorder | Marijuana | Cannabis Intoxication | Substance Related... and other conditionsUnited States
-
Stanford UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)Enrolling by invitation
-
Centre hospitalier de l'Université de Montréal...CompletedCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
Medical University of South CarolinaNational Cancer Institute (NCI)RecruitingTobacco Use Disorder | Marijuana Use | Tobacco Use Cessation | Cannabis Use | Cannabis Use DisorderUnited States
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Brigham and Women's HospitalNot yet recruitingCannabis Use Disorder
-
Boston Children's HospitalNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use | Cannabis Use Disorder | Cannabis IntoxicationUnited States
Clinical Trials on Enhanced Usual Care
-
The Miriam HospitalNational Institute on Aging (NIA)Recruiting
-
Kwong Wah HospitalCompletedHypertension | Blood PressureHong Kong
-
Johns Hopkins UniversityJohns Hopkins Alliance for a Healthier WorldCompleted
-
Seattle Children's HospitalNational Institute of Mental Health (NIMH); University of Washington; Kaiser...Completed
-
SangathLondon School of Hygiene and Tropical MedicineNot yet recruitingAlcohol Use Disorder
-
VA Office of Research and DevelopmentRecruitingSocial Isolation | Suicidal Thoughts and BehaviorsUnited States
-
Laurie McLouthNational Cancer Institute (NCI)Recruiting
-
American UniversityJohns Hopkins University; National Center for Complementary and Integrative... and other collaboratorsActive, not recruitingObesity, ChildhoodUnited States
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of AlbertaCanadian Institutes of Health Research (CIHR)TerminatedChronic Kidney DiseasesCanada